Karma Automotive and Massachusetts-based battery developer Factorial Energy have announced the companies are working together to bring a solid-state battery program to a production vehicle in the ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

US-headquartered battery maker Factorial is supplying its solid-state lithium-metal cells for use in unmanned-drone applications. It’s the first time the company’s FEST (Factorial Electrolyte System ...

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning designed to ...

Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing 3 ...

Building on Stellantis’ $75 million investment in Factorial Energy in 2021, this milestone strengthens the strategic collaboration between the two companies. With this achievement, Stellantis will ...